scorecardresearch
Tuesday, September 23, 2025
TopicPfizer

Topic: Pfizer

China promotes business to foreign corporate leaders like Apple, Pfizer amid intensifying US tariffs

Trump imposed 20% tariffs on all Chinese goods in January, accusing Beijing of not doing enough to stem the flow of fentanyl into the United States, straining relations between both.

Why the Indian health minister didn’t even offer a chair to this vaccine firm executive

In ‘Braving a Viral Storm’, Aashish Chandorkar and Suraj Sudhir examine India’s vaccine journey during the Covid-19 pandemic

Moderna sues Pfizer, BioNTech for infringing its Covid vaccine patent

The company said the rival vaccine makers breached patents that covered its ‘foundational mRNA technology’.

Pfizer’s Covid vaccine safe & effective for children under 5, says US FDA

A lower rate of adverse reactions was seen in trials of the youngest kids, compared with trials of older age groups, the Food and Drug Administration (FDA) report said.

WHO adds Pfizer’s 2-drug antiviral Paxlovid to Covid recommendations for high-risk patients

WHO Guideline Development Group recommends oral drug Paxlovid for patients with non-severe Covid-19 who are at high risk of hospitalisation.

Pfizer’s combo drug Paxlovid could reduce risk of severe Covid by 89%, shows trial in US

Pfizer researchers conducted phase 2/3 clinical trial among unvaccinated Covid patients who had symptoms but weren’t in hospital, and were at high risk of disease becoming severe.

Pfizer begins making hybrid Covid vaccine that targets Omicron & original virus

Pfizer will evaluate the new formulation against an Omicron-specific shot, and determine which is best suited to move forward by March, the drug giant’s CEO Albert Bourla said.

US clears Merck’s Covid pill as it weighs how to ration Pfizer drug

Regulators are signaling they prefer Pfizer’s pill, which they’ve bought more of, but the US will have a lot more early on of Merck’s pill, which is 'better' than no treatment.

Booster dose of 6 Covid vaccines is safe, increases immunity, shows study in Lancet

The study looked at safety, immune response and side-effects of seven vaccines — Oxford-AstraZeneca, Pfizer-BioNTech, Novavax, Janssen, Moderna, Valneva and Curevac.

Drug-resistant infections are becoming increasingly common. Here’s how we can fight it

The lack of appropriate access to medicines gives pathogens an opportunity to infect more people and develop resistance.

On Camera

Bads of Bollywood can’t get more brazenly nepo. The joke’s on us

After watching the most discussed series on Netflix, I was planning to write an asterisk-heavy column. As a tribute to the asterisks in its...

Market regulator SEBI clears Adani Group of impropriety alleged by Hindenburg Research

SEBI probe concluded that purported loans and fund transfers were paid back in full and did not amount to deceptive market practices or unreported related party transactions.

India takes a relook at Russian Su-57, but not for its stealth. Here’s why

India exited the Indo-Russian FGFA programme in 2018. But now it might procure at least 2 squadrons of Su-57 aircraft from Russia and evaluate Russian proposal to manufacture them in India.

India doesn’t give walkovers to Pakistan in war. Here’s why it shouldn’t do it in cricket either

Many really smart people now share the position that playing cricket with Pakistan is politically, strategically and morally wrong. It is just a poor appreciation of competitive sport.